Author:
Mortezaee Keywan,Majidpoor Jamal
Subject
Pharmacology,General Medicine
Reference56 articles.
1. Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy;Rouzbahani;Biomed. Pharmacother.,2022
2. Bispecific antibodies to PD-1 and CTLA4: doubling down on T cells to decouple efficacy from toxicity;Burton;Cancer Discov.,2021
3. Discovery of a novel anti PD-L1 X TIGIT bispecific antibody for the treatment of solid tumors;Xiao;Cancer Treat. Res. Commun.,2021
4. LAG3-PD-1 combo overcome the disadvantage of drug resistance;Wei;Front. Oncol.,2022
5. Indoleamine 2, 3-dioxygenase 1 in circumventing checkpoint inhibitor responses: updated;Charehjoo;Int. Immunopharmacol.,2023
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献